Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TRVI Trevi Therapeutics Inc.

盘后交易 07-19 18:25:22 EDT

2.78

+0.12

+4.51%

盘后2.78

+0.000.00%

16:02 EDT

最高2.81	最低2.67	成交量52.12万
今开2.68	昨收2.66	日振幅5.26%
总市值1.96亿	流通市值1.13亿	总股本7,044万
成交额142.66万	换手率1.28%	流通股本4,081万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TRVI","market":"US","secType":"STK","nameCN":"Trevi Therapeutics Inc.","latestPrice":2.78,"timestamp":1721419200000,"preClose":2.66,"halted":0,"volume":521172,"hourTrading":{"tag":"盘后","latestPrice":2.78,"preClose":2.78,"latestTime":"16:02 EDT","volume":2378,"amount":6610.839999999999,"timestamp":1721419332915},"delay":0,"floatShares":40808008,"shares":70435093,"eps":-0.338162,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.12,"latestTime":"07-19 18:25:22 EDT","open":2.68,"high":2.81,"low":2.67,"amount":1426622.200268,"amplitude":0.052632,"askPrice":2.89,"askSize":462,"bidPrice":2.67,"bidSize":527,"shortable":3,"etf":0,"ttmEps":-0.338162,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721433600000},"adr":0,"listingDate":1557201600000,"adjPreClose":2.66,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.78,"preClose":2.78,"latestTime":"16:02 EDT","volume":2378,"amount":6610.839999999999,"timestamp":1721419332915},"volumeRatio":3.259896,"impliedVol":0.8945,"impliedVolPercentile":0.2183},"requestUrl":"/m/hq/s/TRVI/wiki","defaultTab":"wiki","newsList":[{"id":"2452884302","title":"Trevi Therapeutics, Inc.盘中异动 大幅上涨5.26%报2.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452884302","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452884302?lang=zh_cn&edition=full","pubTime":"2024-07-20 03:29","pubTimestamp":1721417370,"startTime":"0","endTime":"0","summary":"北京时间2024年07月20日03时29分，Trevi Therapeutics, Inc.股票出现波动，股价急速拉升5.26%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720032930af9333c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720032930af9333c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TRVI","BK4139","BK4007"],"gpt_icon":0},{"id":"2452571455","title":"Trevi Therapeutics, Inc.盘中异动 下午盘股价大跌5.28%报2.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452571455","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452571455?lang=zh_cn&edition=full","pubTime":"2024-07-19 03:13","pubTimestamp":1721329982,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日03时13分，Trevi Therapeutics, Inc.股票出现异动，股价快速下跌5.28%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.13%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719031302941f8677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719031302941f8677&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","TRVI","BK4139"],"gpt_icon":0},{"id":"2452165162","title":"Trevi Therapeutics, Inc.盘中异动 股价大跌5.17%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452165162","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452165162?lang=zh_cn&edition=full","pubTime":"2024-07-18 00:27","pubTimestamp":1721233635,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日00时27分，Trevi Therapeutics, Inc.股票出现异动，股价急速下跌5.17%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.98%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180027169681db7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180027169681db7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TRVI","LENZ","BK4007"],"gpt_icon":0},{"id":"2451843625","title":"Trevi Therapeutics, Inc.盘中异动 大幅拉升5.36%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451843625","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451843625?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:01","pubTimestamp":1721052082,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日22时01分，Trevi Therapeutics, Inc.股票出现波动，股价大幅拉升5.36%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152201229681cd32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152201229681cd32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRVI","LENZ","BK4139"],"gpt_icon":0},{"id":"2450753399","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨6.05%报2.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450753399","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450753399?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:31","pubTimestamp":1720791100,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时31分，Trevi Therapeutics, Inc.股票出现异动，股价急速拉升6.05%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071221314095ad9c54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071221314095ad9c54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","TRVI","BK4139"],"gpt_icon":0},{"id":"2449701958","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449701958","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449701958?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:42","pubTimestamp":1720449725,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时42分，Trevi Therapeutics, Inc.股票出现波动，股价急速拉升6.98%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082242059681aad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082242059681aad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","TRVI","BK4139"],"gpt_icon":0},{"id":"2448199465","title":"Trevi Therapeutics, Inc.盘中异动 临近收盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448199465","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448199465?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:44","pubTimestamp":1719949483,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时44分，Trevi Therapeutics, Inc.股票出现异动，股价急速跳水5.19%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703034443af90380b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703034443af90380b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVI","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2446768907","title":"Trevi Therapeutics, Inc.盘中异动 早盘股价大涨6.12%报3.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446768907","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446768907?lang=zh_cn&edition=full","pubTime":"2024-06-28 22:40","pubTimestamp":1719585648,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日22时40分，Trevi Therapeutics, Inc.股票出现异动，股价大幅上涨6.12%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628224049941f2565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628224049941f2565&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TRVI","BK4007"],"gpt_icon":0},{"id":"2446507555","title":"Trevi Therapeutics, Inc.盘中异动 早盘股价大涨5.28%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446507555","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446507555?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:02","pubTimestamp":1719496931,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时02分，Trevi Therapeutics, Inc.股票出现波动，股价大幅拉升5.28%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062722021296817866&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062722021296817866&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVI","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2444249327","title":"Trevi Therapeutics, Inc.盘中异动 快速跳水5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444249327","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444249327?lang=zh_cn&edition=full","pubTime":"2024-06-20 23:34","pubTimestamp":1718897692,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日23时34分，Trevi Therapeutics, Inc.股票出现波动，股价快速下跌5.48%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620233453af8e7757&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620233453af8e7757&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","TRVI","BK4139"],"gpt_icon":0},{"id":"2444197917","title":"Trevi Therapeutics, Inc.盘中异动 下午盘股价大涨5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444197917","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444197917?lang=zh_cn&edition=full","pubTime":"2024-06-18 01:04","pubTimestamp":1718643876,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日01时04分，Trevi Therapeutics, Inc.股票出现异动，股价急速上涨5.66%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061801043696814ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061801043696814ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","TRVI"],"gpt_icon":0},{"id":"2443672783","title":"Trevi Therapeutics, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443672783","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443672783?lang=zh_cn&edition=full","pubTime":"2024-06-14 23:25","pubTimestamp":1718378724,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日23时25分，Trevi Therapeutics, Inc.股票出现波动，股价大幅下挫5.05%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。消息层面，截至23时25分，《Rodman & Renshaw首予Trevi Therapeutics买入评级，目标价7美元》资讯为影响Trevi Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614232524af8da51d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614232524af8da51d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVI","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2442557347","title":"Trevi Therapeutics, Inc.盘中异动 早盘急速上涨5.77%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442557347","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442557347?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:33","pubTimestamp":1718199200,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时33分，Trevi Therapeutics, Inc.股票出现异动，股价急速上涨5.77%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213320aef49732&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213320aef49732&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TRVI","BK4007"],"gpt_icon":0},{"id":"2442574840","title":"Trevi Therapeutics, Inc.盘中异动 快速跳水5.33%报2.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442574840","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442574840?lang=zh_cn&edition=full","pubTime":"2024-06-10 22:18","pubTimestamp":1718029127,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日22时18分，Trevi Therapeutics, Inc.股票出现异动，股价快速下挫5.33%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610221847af8cc52b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610221847af8cc52b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TRVI","BK4007"],"gpt_icon":0},{"id":"2441740193","title":"Trevi Therapeutics, Inc.盘中异动 快速下跌5.07%报2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441740193","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441740193?lang=zh_cn&edition=full","pubTime":"2024-06-07 01:20","pubTimestamp":1717694452,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日01时20分，Trevi Therapeutics, Inc.股票出现异动，股价快速下挫5.07%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607012053aef3d5fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607012053aef3d5fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TRVI","BK4007"],"gpt_icon":0},{"id":"2440496661","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440496661","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440496661?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:51","pubTimestamp":1717422669,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时51分，Trevi Therapeutics, Inc.股票出现异动，股价快速拉升5.45%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603215109af8ba7bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603215109af8ba7bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","TRVI"],"gpt_icon":0},{"id":"2437140542","title":"Trevi Therapeutics, Inc.盘中异动 急速跳水5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437140542","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437140542?lang=zh_cn&edition=full","pubTime":"2024-05-23 02:15","pubTimestamp":1716401726,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日02时15分，Trevi Therapeutics, Inc.股票出现异动，股价急速跳水5.49%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523021526861ee624&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523021526861ee624&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TRVI","BK4007"],"gpt_icon":0},{"id":"2435379549","title":"Trevi Therapeutics, Inc.盘中异动 急速上涨5.49%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435379549","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435379549?lang=zh_cn&edition=full","pubTime":"2024-05-15 01:04","pubTimestamp":1715706262,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日01时04分，Trevi Therapeutics, Inc.股票出现异动，股价大幅拉升5.49%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150104237a59dc97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150104237a59dc97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRVI","LENZ","BK4139"],"gpt_icon":0},{"id":"2435374806","title":"Trevi Therapeutics, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435374806","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435374806?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:53","pubTimestamp":1715612036,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时53分，Trevi Therapeutics, Inc.股票出现波动，股价急速跳水5.13%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051322535787e878dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051322535787e878dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","TRVI","BK4139"],"gpt_icon":0},{"id":"2435356931","title":"Trevi Therapeutics, Inc.2024财年第一财季实现净利润-10.90百万美元，同比减少70.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435356931","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435356931?lang=zh_cn&edition=full","pubTime":"2024-05-13 00:19","pubTimestamp":1715530791,"startTime":"0","endTime":"0","summary":"3月31日，Trevi Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-10.90百万美元，同比减少70.31%；其中营业收入为0.00美元，每股基本收益为-0.11美元。从资产负债表来看，Trevi Therapeutics, Inc.总负债6.23百万美元，其中短期债务322000.00美元，资产负债比为12.61，流动比率为14.54。机构评级：截至2024年3月31日，当前有5家机构对Trevi Therapeutics, Inc.目标价做出预测，其中目标均价为7.40美元，其中最低目标价为6.00美元，最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130020018afe925c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130020018afe925c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVI","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.trevitherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0534},{"period":"1month","weight":-0.0112},{"period":"3month","weight":-0.0617},{"period":"6month","weight":0.9704},{"period":"1year","weight":0.1982},{"period":"ytd","weight":0.9851}],"compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":0.0076},{"period":"3month","weight":0.1161},{"period":"6month","weight":0.1456},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.1627}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Trevi Therapeutics, Inc.于2011年3月17日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发和商业化纳布啡ER，以治疗严重的神经介导的疾病。公司目前正在开发纳布啡ER，用于治疗患有特发性肺纤维化或IPF的慢性瘙痒，慢性咳嗽，以及帕金森病患者的左旋多巴诱导的运动障碍或LID。这些病症具有共同的病理生理学，其通过中枢和外周神经系统中的阿片受体介导。由于纳布啡作为阿片受体调节剂的作用机制，该公司认为它有可能有效治疗这些疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.128325},{"month":2,"riseRate":0.8,"avgChangeRate":0.214835},{"month":3,"riseRate":0.4,"avgChangeRate":0.397594},{"month":4,"riseRate":0.4,"avgChangeRate":0.130673},{"month":5,"riseRate":0,"avgChangeRate":-0.142766},{"month":6,"riseRate":0.833333,"avgChangeRate":0.27262},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.103584},{"month":8,"riseRate":0.2,"avgChangeRate":-0.104475},{"month":9,"riseRate":0,"avgChangeRate":-0.155733},{"month":10,"riseRate":0.2,"avgChangeRate":-0.120785},{"month":11,"riseRate":0.2,"avgChangeRate":-0.086318},{"month":12,"riseRate":0.6,"avgChangeRate":-0.027412}],"exchange":"NASDAQ","name":"Trevi Therapeutics Inc.","nameEN":"Trevi Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Trevi Therapeutics Inc.(TRVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Trevi Therapeutics Inc.,TRVI,Trevi Therapeutics Inc.股票,Trevi Therapeutics Inc.股票老虎,Trevi Therapeutics Inc.股票老虎国际,Trevi Therapeutics Inc.行情,Trevi Therapeutics Inc.股票行情,Trevi Therapeutics Inc.股价,Trevi Therapeutics Inc.股市,Trevi Therapeutics Inc.股票价格,Trevi Therapeutics Inc.股票交易,Trevi Therapeutics Inc.股票购买,Trevi Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Trevi Therapeutics Inc.(TRVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}